Heterologous boosting of nonrelated toxoid immunity during acute Puumala hantavirus infection.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
26 03 2021
Historique:
received: 12 05 2020
revised: 01 01 2021
accepted: 22 02 2021
pubmed: 9 3 2021
medline: 25 5 2021
entrez: 8 3 2021
Statut: ppublish

Résumé

Persistence of immune memory in humans is a crucial yet poorly understood aspect of immunology. Here we have studied the effect of Puumala hantavirus infection on unrelated, pre-existing immune memory by studying T cell- and antibody responses against toxoid vaccine antigens of diphtheria, tetanus and pertussis in a cohort of 45 patients. We found that tetanus- and pertussis -specific IgG concentrations elevate during acute Puumala virus infection. Increase in vaccine IgG was associated with proliferation of heterologous T cells. Interestingly, increases in tetanus-specific IgG persisted a year after the infection while pertussis-specific IgG declined rapidly; a difference in IgG kinetics resembling the difference seen after vaccination against tetanus and pertussis. These results suggest that persistence of immune memory is facilitated by heterologous boosting of old memory during memory formation against newly encountered antigens. They also show that different toxoid antigens may be treated differently. Our study gives new insight into how immune memory formation may alter pre-existing immune memory, and also shows that heterologous immunity may have an impact on vaccination outcomes.

Identifiants

pubmed: 33678453
pii: S0264-410X(21)00226-7
doi: 10.1016/j.vaccine.2021.02.046
pii:
doi:

Substances chimiques

Antibodies, Bacterial 0
Diphtheria-Tetanus-Pertussis Vaccine 0
Diphtheria-Tetanus-acellular Pertussis Vaccines 0
Tetanus Toxoid 0
Toxoids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1818-1825

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Tiitus Lamponen (T)

Department of Bacteriology and Immunology, University of Helsinki, PO BOX 21 (Haartmaninkatu 3), FI-00014 Helsinki, Finland; Translational Immunology Research Program, University of Helsinki, PO. Box 63 (Haartmaninkatu 8), FI-00014 Helsinki, Finland. Electronic address: tiitus.lamponen@helsinki.fi.

Iivo Hetemäki (I)

Department of Bacteriology and Immunology, University of Helsinki, PO BOX 21 (Haartmaninkatu 3), FI-00014 Helsinki, Finland; Translational Immunology Research Program, University of Helsinki, PO. Box 63 (Haartmaninkatu 8), FI-00014 Helsinki, Finland.

Heikki J Niemi (HJ)

Department of Bacteriology and Immunology, University of Helsinki, PO BOX 21 (Haartmaninkatu 3), FI-00014 Helsinki, Finland.

Hanna Jarva (H)

Department of Bacteriology and Immunology, University of Helsinki, PO BOX 21 (Haartmaninkatu 3), FI-00014 Helsinki, Finland; Helsinki University Hospital, HUSLAB, Division of Microbiology, Topeliuksenkatu 32, 00290 Helsinki, Finland.

Eliisa Kekäläinen (E)

Department of Bacteriology and Immunology, University of Helsinki, PO BOX 21 (Haartmaninkatu 3), FI-00014 Helsinki, Finland; Helsinki University Hospital, HUSLAB, Division of Microbiology, Topeliuksenkatu 32, 00290 Helsinki, Finland.

Satu Mäkelä (S)

Faculty of Medicine and Health Technology, Tampere University, Kalevantie 4, FI-33100 Tampere, Finland; Department of Internal Medicine, Tampere University Hospital, PO BOX 2000, FI-33521 Tampere, Finland.

Jukka Mustonen (J)

Faculty of Medicine and Health Technology, Tampere University, Kalevantie 4, FI-33100 Tampere, Finland; Department of Internal Medicine, Tampere University Hospital, PO BOX 2000, FI-33521 Tampere, Finland.

Antti Vaheri (A)

Department of Virology, Medicum, University of Helsinki, PO Box 21 (Haartmaninkatu 3), FI-00014 Helsinki, Finland.

T Petteri Arstila (TP)

Department of Bacteriology and Immunology, University of Helsinki, PO BOX 21 (Haartmaninkatu 3), FI-00014 Helsinki, Finland; Translational Immunology Research Program, University of Helsinki, PO. Box 63 (Haartmaninkatu 8), FI-00014 Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH